These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
510 related articles for article (PubMed ID: 23313298)
1. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis. Hu C; Wang J; Xu Y; Li X; Chen H; Bunjhoo H; Xiong W; Xu Y; Zhao J Gene; 2013 Mar; 517(1):65-71. PubMed ID: 23313298 [TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion. Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112 [TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies. Peng B; Cao L; Wang W; Xian L; Jiang D; Zhao J; Zhang Z; Wang X; Yu L Mutagenesis; 2010 Jan; 25(1):41-8. PubMed ID: 19843588 [TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk. Peng B; Cao L; Ma X; Wang W; Wang D; Yu L Mutagenesis; 2010 Jul; 25(4):371-9. PubMed ID: 20360147 [TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk. Zhang C; Li C; Zhu M; Zhang Q; Xie Z; Niu G; Song X; Jin L; Li G; Zheng H PLoS One; 2013; 8(4):e62023. PubMed ID: 23637955 [TBL] [Abstract][Full Text] [Related]
7. [Association of single nucleotide polymorphism in matrix metalloproteinases promoter with susceptibility to ovarian cancer]. Li Y; Wang Y; Kang S; Zhang JH; Guo W; Wang N; Jin X; Fang SM Zhonghua Fu Chan Ke Za Zhi; 2005 Jul; 40(7):472-5. PubMed ID: 16080875 [TBL] [Abstract][Full Text] [Related]
8. Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population. Mirowska-Guzel D; Gromadzka G; Czlonkowski A; Czlonkowska A J Neuroimmunol; 2009 Sep; 214(1-2):113-7. PubMed ID: 19628284 [TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Fang S; Jin X; Wang R; Li Y; Guo W; Wang N; Wang Y; Wen D; Wei L; Zhang J Carcinogenesis; 2005 Feb; 26(2):481-6. PubMed ID: 15528217 [TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma. Zinzindohoué F; Blons H; Hans S; Loriot MA; Houllier AM; Brasnu D; Laccourreye O; Tregouet DA; Stucker I; Laurent-Puig P Anticancer Res; 2004; 24(3b):2021-6. PubMed ID: 15274394 [TBL] [Abstract][Full Text] [Related]
12. Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer. Su L; Zhou W; Asomaning K; Lin X; Wain JC; Lynch TJ; Liu G; Christiani DC Carcinogenesis; 2006 May; 27(5):1024-9. PubMed ID: 16311244 [TBL] [Abstract][Full Text] [Related]
13. Haplotypes in matrix metalloproteinase gene cluster on chromosome 11q22 contribute to the risk of lung cancer development and progression. Sun T; Gao Y; Tan W; Ma S; Zhang X; Wang Y; Zhang Q; Guo Y; Zhao D; Zeng C; Lin D Clin Cancer Res; 2006 Dec; 12(23):7009-17. PubMed ID: 17145822 [TBL] [Abstract][Full Text] [Related]
14. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis]. Kang S; Wang Y; Zhang JH; Jin X; Fang SM; Li Y Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):601-4. PubMed ID: 16202315 [TBL] [Abstract][Full Text] [Related]
15. Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis. Liu D; Guo H; Li Y; Xu X; Yang K; Bai Y PLoS One; 2012; 7(2):e31251. PubMed ID: 22348060 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase variants associated with risk and clinical outcome of esophageal cancer. Zhang L; Xi RX; Zhang XZ Genet Mol Res; 2015 May; 14(2):4616-24. PubMed ID: 25966235 [TBL] [Abstract][Full Text] [Related]
17. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma. Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295 [TBL] [Abstract][Full Text] [Related]
18. MMP1, 2, 3, 7, and 9 gene polymorphisms and urinary cancer risk: a meta-analysis. Tao L; Li Z; Lin L; Lei Y; Hongyuan Y; Hongwei J; Yang L; Chuize K Genet Test Mol Biomarkers; 2015 Oct; 19(10):548-55. PubMed ID: 26301605 [TBL] [Abstract][Full Text] [Related]
19. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Zhu Y; Spitz MR; Lei L; Mills GB; Wu X Cancer Res; 2001 Nov; 61(21):7825-9. PubMed ID: 11691799 [TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of associations between polymorphisms in the promoter regions of matrix metalloproteinases and the risk of colorectal cancer. Liu D; Duan W; Guo H; Xu X; Bai Y Int J Colorectal Dis; 2011 Sep; 26(9):1099-105. PubMed ID: 21538057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]